Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.80 | -$0.00 | -$0.40 |
Q2 2024 | 3 | -$0.55 | -$0.00 | -$0.27 |
Q3 2024 | 1 | -$0.54 | -$0.00 | -$0.27 |
Q4 2024 | 3 | -$0.37 | -$0.17 | -$0.30 |
Q1 2025 | 1 | -$0.29 | -$0.00 | -$0.15 |
Q2 2025 | 1 | -$0.60 | -$0.00 | -$0.30 |
Q3 2025 | 1 | -$0.54 | -$0.00 | -$0.27 |
Q4 2025 | 1 | -$0.54 | -$0.00 | -$0.27 |
Q1 2026 | 1 | -$0.59 | -$0.00 | -$0.29 |
Q2 2026 | 1 | -$0.59 | -$0.00 | -$0.29 |
Q3 2026 | 1 | -$0.34 | -$0.00 | -$0.17 |
Q4 2026 | 1 | -$0.33 | -$0.00 | -$0.16 |
Generation Bio Co. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-0.28 by $0.05. The company had revenue of 7.55 M for the quarter and had revenue of 5.90 M for the year. Generation Bio Co. has generated $-2 earnings per share over the last year ($-1.96 diluted earnings per share) and currently has a price-to-earnings ratio of -0.49. Generation Bio Co. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/06/2024 | Q3 2024 | -$0.28 | -$0.23 | 0.05 | $1.97 M | $7.55 M |
08/07/2024 | Q2 2024 | -$0.27 | -$0.31 | -0.04 | $1.96 M | $4.09 M |
05/13/2024 | Q1 2024 | -$0.36 | -$1.12 | -0.76 | $4.06 M | |
03/06/2024 | Q4 2023 | -$0.41 | -$0.53 | -0.12 | $2.88 M | |
11/09/2023 | Q3 2023 | -$0.51 | -$0.43 | 0.08 | $1.09 M | $2.15 M |
08/02/2023 | Q2 2023 | -$0.49 | -$0.47 | 0.02 | $5.92 M | $880,000 |
05/10/2023 | Q1 2023 | -$0.39 | -$0.46 | -0.07 | $0 | |
02/23/2023 | Q4 2022 | -$0.57 | -$0.51 | 0.06 | $0 | |
11/03/2022 | Q3 2022 | -$0.67 | -$0.53 | 0.14 | $0 | |
08/04/2022 | Q2 2022 | -$0.63 | -$0.65 | -0.02 | $2.50 M | $0 |
05/05/2022 | Q1 2022 | -$0.52 | -$0.61 | -0.09 | $0 | |
02/24/2022 | Q4 2021 | -$0.57 | -$0.55 | 0.02 | $0 | |
11/10/2021 | Q3 2021 | -$0.55 | -$0.56 | -0.01 | $0 | |
08/11/2021 | Q2 2021 | -$0.47 | -$0.55 | -0.08 | $0 | |
05/12/2021 | Q1 2021 | -$0.46 | -$0.46 | 0 | $0 | |
03/18/2021 | Q4 2020 | -$0.52 | -$0.53 | -0.01 | $0 | |
11/10/2020 | Q3 2020 | -$0.45 | -$0.46 | -0.01 | $0 | |
08/11/2020 | Q2 2020 | -$0.60 | -$1.50 | -0.9 | $0 | |
03/30/2020 | Q1 2020 | -$0.43 | $0 | |||
12/30/2019 | Q4 2019 | -$0.51 | $0 |
Generation Bio Co. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
In the previous quarter, Generation Bio Co. (:GBIO) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.28 by $0.05.
The conference call for Generation Bio Co.'s latest earnings report can be listened to online.
The conference call transcript for Generation Bio Co.'s latest earnings report can be read online.
Generation Bio Co. (:GBIO) has a recorded annual revenue of $5.90 M.
Generation Bio Co. (:GBIO) has a recorded net income of $5.90 M. Generation Bio Co. has generated $-1.96 earnings per share over the last four quarters.
Generation Bio Co. (:GBIO) has a price-to-earnings ratio of -0.49 and price/earnings-to-growth ratio is -0.06.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED